Executives On The Move: Hookipa Hooks Development Head From Evotec
• By Scrip Team
Latest moves in biopharma leadership include Mark Winderlich becoming chief development officer at Hookipa Pharma and Dianne Hol leaving AstraZeneca to join Lundbeck, where she becomes EVP people and organization.
• Source: Alamy
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
Joshi joins the parent company of Citeline, which houses flagship publications Scrip and Pink Sheet, to focus on AI, business harmonization and long-term growth.
A deal last year with Sanofi relieved Novavax of commercial costs for the COVID-19 vaccine Nuvaxovid, allowing the company to focus on R&D and finding partners for its other vaccines.
Drug manufacturers may find comfort in the appointment of former biotech CEO and entrepreneur George Tidmarsh to lead the FDA’s Center for Drug Evaluation and Research.
A new small-molecule approach to turning on beneficial genes to counteract disease-causing mutations is being pioneered by Insmed’s UK-based scientists.